We are live on
!
Find out more
HAG
HighPoint Advisor Group Portfolio holdings
AUM
$2.84B
1-Year Est. Return
31.94%
This Fund
S&P 500
This Quarter
Est. Return
+16.95%
1 Year Est. Return
+31.94%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$821M
AUM Growth
+$268M
(+49%)
Cap. Flow
+$155M
Cap. Flow
% of AUM
18.9%
Top 10 Holdings %
Top 10 Hldgs %
32.96%
Holding
536
New
147
Increased
262
Reduced
76
Closed
40
Avg Time Held
8.4
quarters
Top 10 Avg Time Held
5.7
quarters
Top 20 Avg Time Held
11.3
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$14.1M |
| 2 |
CME Group
CME
|
+$10.3M |
| 3 |
Tesla
TSLA
|
+$8.97M |
| 4 |
AbbVie
ABBV
|
+$8.36M |
| 5 |
Abbott
ABT
|
+$8.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$12.4M |
| 2 |
Fiserv Inc
FISV
|
+$6.48M |
| 3 |
Berkshire Hathaway Class A
BRK.A
|
+$2.65M |
| 4 |
Moderna
MRNA
|
+$1.34M |
| 5 |
Tiziana Life Sciences
TLSA
|
+$1.34M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.32% |
| 2 | Healthcare | 14.7% |
| 3 | Consumer Discretionary | 13.39% |
| 4 | Financials | 12.62% |
| 5 | Communication Services | 10.1% |
Similar funds
FMC
ORCP
PCIG
DIG
BDLIB
EMFAT
WGI
RL
HighPoint Advisor Group's Q4 2020 Portfolio in Review
As of Q4 2020, HighPoint Advisor Group held 536 positions worth $821M, up 49% from $553M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
HighPoint Advisor Group deployed $155M of net new capital in Q4 2020, opening 147 new positions and adding to 262 existing holdings. Its largest new stake was CME Group: 60,752 shares worth $11.7M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Clorox, an estimated $12.4M trimmed.
- HighPoint Advisor Group's largest Q4 2020 buy was CME Group: 60,752 shares worth $11.7M.
- HighPoint Advisor Group added most to Apple in Q4 2020, an estimated $14.1M increase.
- HighPoint Advisor Group's biggest Q4 2020 reduction was Clorox, cutting an estimated $12.4M.
- HighPoint Advisor Group fully exited Tiziana Life Sciences in Q4 2020, selling an estimated $1.34M.
- HighPoint Advisor Group's ten largest holdings make up 33% of its $821M portfolio in Q4 2020.
- HighPoint Advisor Group opened 147 new positions and closed 40 in Q4 2020.
- HighPoint Advisor Group's portfolio value rose 49% quarter-over-quarter to $821M.
Based on HighPoint Advisor Group's 13F filing for Q4 2020, filed 10 Feb 2021.